Frontiers in Cardiovascular Medicine | Cardiovascular Metabolism

Editorial

Published on 27 Feb 2024

Editorial: The interplay between oxidative stress, immune cells and inflammation in cardiovascular diseases

in Cardiovascular Metabolism

R. Nosalski
M. Siedlinski
K. B. Neves
C. Monaco

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1385809

1,529 views

Original Research

Published on 26 Feb 2024

Association of systemic inﬂammation response index with all-cause mortality as well as cardiovascular mortality in patients with chronic kidney disease

in Cardiovascular Metabolism

Lu Wei
Shiqing Mao
Xianhong Liu
Chuanqi Zhu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363949

2,489 views
2 citations

Clinical Trial

Published on 21 Feb 2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

in Cardiovascular Metabolism

Lucas Lage Marinho
Fabiana Hanna Rached
Aleksandra Tiemi Morikawa
Thauany Martins Tavoni
Ana Paula Toniello Cardoso
Roberto Vitor Almeida Torres
Antonildes Nascimento Assuncao
Carlos Vicente Serrano
Cesar Higa Nomura
Raul Cavalcante Maranhão

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1342832

2,184 views

Original Research

Published on 20 Feb 2024

Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease

in Cardiovascular Metabolism

Mengjiao Zhang
Jiechao Niu
Mengmeng Xu
Erhu Wei
Peng Liu
Guangyao Sheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367108

2,625 views

Review

Published on 05 Feb 2024

So close, yet so far away: the relationship between MAM and cardiac disease

in Cardiovascular Metabolism

Bo Lu
Xiaozhe Chen
Yulong Ma
Mingtai Gui
Lei Yao
Jianhua Li
Mingzhu Wang
Xunjie Zhou
Deyu Fu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1353533

4,101 views
3 citations

Original Research

Published on 08 Jan 2024

Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice

in Cardiovascular Metabolism

Niklas Dörmann
Elke Hammer
Karlotta Struckmann
Julia Rüdebusch
Kirsten Bartels
Kristin Wenzel
Julia Schulz
Stefan Gross
Stefan Schwanz
Elisa Martin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1323760

3,166 views

Editorial

Published on 21 Dec 2023

Editorial: Cardiac energetic efficiency and cardiometabolic diseases

in Cardiovascular Metabolism

Teresa Vanessa Fiorentino
Francesca Cinti
Ram Jagannathan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1352798

1,447 views

Systematic Review

Published on 06 Dec 2023

The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy

in Cardiovascular Metabolism

Sha Su
Xiang Ji
Tong Li
Yu Teng
Baofu Wang
Xiaowan Han
Mingjing Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1291450

4,134 views
2 citations

Original Research

Published on 29 Nov 2023

Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes

in Cardiovascular Metabolism

K. Alluri
B. Srinivas
S. Belmadani
K. Matrougui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1222243

2,127 views
2 citations

Editorial

Published on 13 Oct 2023

Editorial: COVID-19 mechanisms on cardio-vascular dysfunction: from membrane receptors to immune response, volume II

in Cardiovascular Metabolism

Ana Iochabel Soares Moretti
Roberto Schreiber
Amarylis B. A. Wanschel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1278067

1,266 views

Original Research

Published on 06 Oct 2023

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A

in Cardiovascular Metabolism

Julius R. Herting
Jule H. König
Katarina Hadova
Alexander Heinick
Frank U. Müller
Paul Pauls
Matthias D. Seidl
Carolina Soppa
Uwe Kirchhefer

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1239555

2,772 views
1 citation

Editorial

Published on 05 Oct 2023

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases

in Cardiovascular Metabolism

Yuliang Liu
Yingying Guo
Pengyong Li
Haipeng Guo
Man Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1296935

2,022 views

Original Research

Published on 07 Sep 2023

Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases

in Cardiovascular Metabolism

Joanna Sulicka-Grodzicka
Piotr Szczepaniak
Ewelina Jozefczuk
Karol Urbanski
Mateusz Siedlinski
Łukasz Niewiara
Bartłomiej Guzik
Grzegorz Filip
Bogusław Kapelak
Karol Wierzbicki

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1230051

2,475 views
5 citations

Original Research

Published on 04 Sep 2023

Bibliometric research on analysis of links between periodontitis and cardiovascular diseases

in Cardiovascular Metabolism

Kuangyun Tang
Yongjia Wu
Qianhan Zheng
Xuepeng Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1255722

4,216 views
6 citations

Review

Published on 04 Sep 2023

Ferroptosis: a new strategy for cardiovascular disease

in Cardiovascular Metabolism

Yuyuan Wang
Junduo Wu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1241282

4,002 views
7 citations

Original Research

Published on 15 Aug 2023

Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes

in Cardiovascular Metabolism

Daniel Tarnowski
Anna-Lena Feder
Maximilian Trum
Klaus-Georg Kreitmeier
Laura Stengel
Lars S. Maier
Can Martin Sag

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1190099

2,365 views
7 citations

Navigation group

Articles

Editorial: The interplay between oxidative stress, immune cells and inflammation in cardiovascular diseases

Association of systemic inﬂammation response index with all-cause mortality as well as cardiovascular mortality in patients with chronic kidney disease

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease

So close, yet so far away: the relationship between MAM and cardiac disease

Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice

Editorial: Cardiac energetic efficiency and cardiometabolic diseases

The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy

Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes

Editorial: COVID-19 mechanisms on cardio-vascular dysfunction: from membrane receptors to immune response, volume II

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases

Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases

Bibliometric research on analysis of links between periodontitis and cardiovascular diseases

Ferroptosis: a new strategy for cardiovascular disease

Ibrutinib impairs IGF-1-dependent activation of intracellular Ca handling in isolated mouse ventricular myocytes